FIELD: chemistry.
SUBSTANCE: present invention relates to a compound having general structural formula , in which n is equal to 1 or 5 and R6 is COOH or CH2OPO3H2, to a pharmaceutically acceptable salt of the said compound. The invention also pertains to a pharmaceutical composition based on the said compounds or their pharmaceutically acceptable salts, meant for inducing or boosting immunoreaction in a subject.
EFFECT: invention relates to a method of inducing or boosting immunoreaction in a subject, as well as to a method of relieving or essentially preventing an infectious disease, involving administration of an effective amount of the said compound to the subject.
7 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
SOME AMINO ALKYL GLUCOSE AMINIDE PHOSPHATE DERIVATIVES AND THEREOF APPLICATION | 2004 |
|
RU2544850C2 |
COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
MULTI-COMPONENT IMMUNOGENIC COMPOSITION FOR PREVENTING DOSEASE, CAUSED BY β-HEMOLYTIC STREPTOCCOCI (BHS) | 2009 |
|
RU2478396C2 |
TREATMENT AND PREVENTION OF NEURODGENERATIVE DISEASES WITH USE OF GENE THERAPY | 2008 |
|
RU2471487C2 |
RECOMBINANT VACCINE AGAINST AVIAN FLU AND APPLICATION THEREOF | 2009 |
|
RU2559527C2 |
FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
FMDV-E2 FUSION PROTEINS AND USE THEREOF | 2016 |
|
RU2714428C2 |
RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
DNA PLASMIDS SHOWING HIGH EXPRESSION AND STABILITY | 2007 |
|
RU2456346C2 |
COMPOSITIONS AND METHODS OF MAMMARY GLAND CANCER THERAPY AND DIAGNOSTICS | 2001 |
|
RU2344831C2 |
Authors
Dates
2010-05-20—Published
2004-01-06—Filed